Citations

Clear

272 citation(s) found for "Watson, DA".

Interictal Scalp Electroencephalography and Intraoperative Electrocorticography in Magnetic Resonance Imaging–Negative Temporal Lobe Epilepsy Surgery
Burkholder, David B. , Šulc, Vlastimil , Hoffman, E. Matthew , Cascino, Gregory D. , So, Elson L., Marsh, W. Richard , Meyer, Fredric B. , Wass, C. Thomas, Watson, Robert E. , Van Gompel, Jamie J, Britton, Jeffrey W. , Gompel, Jamie J. Van , Giannini, Caterina , Worrell, Gregory A. , Burkholder, David B

Mayo Clinic

JAMA Neurology | April 28, 2014 | Volume: 71 | Issue: 6 | Pages: 702

10.1001/jamaneurol.2014.585 | PMID 24781216 Get It

From the notch to a glioma grading system: the neurological contributions of James Watson Kernohan
Safavi‐Abbasi, Sam, Maurer, Adrian J., Archer, Jacob, Sughrue, Michael E. , Hanel, Ricardó A. , Theodore, Nicholas , Preul, Mark C.

Mayo Clinic

Neurosurgical Focus | April 1, 2014 | Volume: 36 | Issue: 4 | Pages: E4

10.3171/2014.1.focus13575 | PMID 24684337 Get It

During his lifetime and a career spanning 42 years, James Watson Kernohan made numerous contributions to neuropathology, neurology, and neurosurgery. One of these, the phenomenon of ipsilateral, false localizing signs caused by compression of the contralateral cerebral peduncle against the tentorial edge, has widely become known as “Kernohan's notch” and continues to bear his name. The other is a grading system for gliomas from a neurosurgical viewpoint that continues to be relevant for grading of glial tumors 60 years after its introduction. In this paper, the authors analyze these two major contributions in detail within the context of Kernohan's career and explore how they contributed to the development of neurosurgical procedures.
Clinical, electrophysiologic, and imaging features of zoster‐associated limb paresis
Jones, Lyell K. , Haatem, Reda, Watson, James C. , Jones, Lyell K

Mayo Clinic

Muscle & Nerve | December 4, 2013 | Volume: 50 | Issue: 2 | Pages: 177-185

10.1002/mus.24141 | PMID 24638224 Get It

ABSTRACTIntroduction: Paresis is a long‐recognized complication of herpes zoster, but there has been comparatively little study of zoster‐associated limb paresis (ZALP). Methods: In this study we reviewed 49 Mayo Clinic patients with ZALP. Results: The mean age of onset was 71 years, 67% were men, and the lower limb was affected in 55%. The mean weakness score was 2.0 (0 = normal strength, 4 = plegia). Most patients developed postherpetic neuralgia (PHN, 92% at 1 month and 65% at 3 months), and the average minimum duration of weakness was 193 days. ZALP was caused by radiculopathy (37%), plexopathy (41%), mononeuropathy (14%), and radiculoplexus neuropathy (8%). MRI demonstrated nerve enlargement, T2 signal prolongation, or enhancement in a majority (64%) of affected plexi and peripheral nerves. Conclusions: ZALP is associated with considerable weakness. It typically lasts at least several months, localizes to plexus or peripheral nerve in 63%, and is associated with high rates of PHN. Muscle Nerve 50:177–185, 2014
Diaphragm depth in normal subjects
Shahgholi, Leili , Baria, Michael R. , Sorenson, Eric J. , Harper, Caitlin J., Watson, James C. , Strommen, Jeffrey A., Boon, Andrea J.

Mayo Clinic

Muscle & Nerve | July 19, 2013 | Volume: 49 | Issue: 5 | Pages: 666-668

10.1002/mus.23953 | PMID 23873396 Get It

ABSTRACTIntroduction: Needle electromyography (EMG) of the diaphragm carries the potential risk of pneumothorax. Knowing the approximate depth of the diaphragm should increase the test's safety and accuracy. Methods: Distances from the skin to the diaphragm and from the outer surface of the rib to the diaphragm were measured using B mode ultrasound in 150 normal subjects. Results: When measured at the lower intercostal spaces, diaphragm depth varied between 0.78 and 4.91 cm beneath the skin surface and between 0.25 and 1.48 cm below the outer surface of the rib. Using linear regression modeling, body mass index (BMI) could be used to predict diaphragm depth from the skin to within an average of 1.15 mm. Conclusions: Diaphragm depth from the skin can vary by more than 4 cm. When image guidance is not available to enhance accuracy and safety of diaphragm EMG, it is possible to reliably predict the depth of the diaphragm based on BMI. Muscle Nerve 49: 666–668, 2014
Magnetic Resonance Imaging in Patients with Recently Implanted Pacemakers
Friedman, Hannah, Acker, Nancy, Dalzell, Connie, Shen, Win K., Asirvatham, Samuel J. , Cha, Yong‐Mei , Hodge, David O. , Felmlee, Joel P. , Watson, Robert E. , Friedman, Paul A. , Friedman, Hannah L, Asirvatham, Samuel J

Mayo Clinic

Pacing and Clinical Electrophysiology | July 4, 2013 | Volume: 36 | Issue: 9 | Pages: 1090-1095

10.1111/pace.12213 | PMID 23826621 Get It

BackgroundRecent studies have shown that magnetic resonance imaging (MRI) of patients with pacemakers can be safely performed under careful monitoring, but they excluded patients with recently implanted devices. Patients with recent implants may be at a greater risk for complications during MRI imaging due to lack of lead and wound maturity.MethodsWe implemented a clinical protocol for MRI imaging of patients with implanted cardiac devices, and prospectively collected data. For this study, we retrospectively analyzed two groups of patients: those with recently implanted (≤42 days) and nonrecently implanted (>42 days) leads at the time of MRI scanning. All devices were interrogated before and after scanning, and were reprogrammed during the scan as per protocol.ResultsOf the 219 scans (in 171 patients), eight included patients with recently implanted (range: 7–36 days) and 211 with only nonrecently implanted pacemaker leads. During the scan, there were no complications in the early or late group. In one patient imaged 79 days postimplant, frequent premature ventricular complexes were noted during the scan, requiring no action. No patient reported pain during or immediately after the procedure. No clinically significant changes in function were seen at subsequent follow up (average 104 days post‐MRI). Compared to patients with nonrecently implanted leads, there was no difference in any parameter between the two groups.ConclusionsWith a strong clinical indication and with careful monitoring, MRI imaging is feasible in patients with recently implanted pacemakers, although experience is limited.
Operationalizing protocol differences for EADC‐ADNI manual hippocampal segmentation
Boccardi, Marina , Bocchetta, Martina , Ganzola, Rossana , Robitaille, Nicolas , Redolfi, Alberto , Duchesne, Simon , Jack, Clifford R. , Frisoni, Giovanni B. , Initiative, EADC‐ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Segmentation and for the Alzheimer's Disease Neuroimaging, Bartzokis, George, Csernansky, John G., deToledo‐Morrell, Leyla, Lehéricy, Stéphane , Malykhin, Nikolai , Pantel, Johannes, Pruessner, Jens C. , Watson, Craig, Boccardi, Marina , Frisoni, Giovanni B. , Initiative, EADC‐ADNI Working Group on The Harmonized Protocol for Manual Hippocampal Segmentation and for the Alzheimer's Disease Neuroimaging, Leon, Mony J. de , Killiany, Ronald , Soininen, Hilkka S. , Jack, Clifford R , Bocchetta, Martina

Mayo Clinic

Alzheimer's & Dementia | May 21, 2013 | Volume: 11 | Issue: 2 | Pages: 184-194

10.1016/j.jalz.2013.03.001 | PMID 23706515 Get It

AbstractBackgroundHippocampal volumetry on magnetic resonance imaging is recognized as an Alzheimer's disease (AD) biomarker, and manual segmentation is the gold standard for measurement. However, a standard procedure is lacking. We operationalize and quantitate landmark differences to help a Delphi panel converge on a set of landmarks.MethodsOne hundred percent of anatomic landmark variability across 12 different protocols for manual segmentation was reduced into four segmentation units (the minimum hippocampus, the alveus/fimbria, the tail, and the subiculum), which were segmented on magnetic resonance images by expert raters to estimate reliability and AD‐related atrophy.ResultsIntra‐ and interrater reliability were more than 0.96 and 0.92, respectively, except for the alveus/fimbria, which were 0.86 and 0.77, respectively. Of all AD‐related atrophy, the minimum hippocampus contributed to 67%; tail, 24%; alveus/fimbria, 4%; and the subiculum, 5%.ConclusionsAnatomic landmark variability in available protocols can be reduced to four discrete and measurable segmentation units. Their quantitative assessment will help a Delphi panel to define a set of landmarks for a harmonized protocol.
Two‐dimensional ultrasound imaging of the diaphragm: Quantitative values in normal subjects
Boon, Andrea J. , Harper, Caitlin J., Ghahfarokhi, Leili Shahgholi, Strommen, Jeffrey A., Watson, James C. , Sorenson, Eric J.

Mayo Clinic

Muscle & Nerve | October 16, 2012 | Volume: 47 | Issue: 6 | Pages: 884-889

10.1002/mus.23702 | PMID 23625789 Get It

Introduction : Real time ultrasound imaging of the diaphragm is an under‐used tool in the evaluation of patients with unexplained dyspnea or respiratory failure. Methods : We measured diaphragm thickness and the change in thickness that occurs with maximal inspiration in 150 normal subjects, with results stratified for age, gender, body mass index, and smoking history. Results : The lower limit of normal diaphragm thickness at end expiration or functional residual capacity is 0.15 cm, and an increase of at least 20% in diaphragm thickness from functional residual capacity to total lung capacity is normal. A side to side difference in thickness at end expiration of > 0.33 cm is abnormal. Diaphragm thickness and contractility are minimally affected by age, gender, body habitus, or smoking history. Conclusions : This study confirms previous findings in much smaller groups of normal controls for quantitative ultrasound of the diaphragm and provides data that can be applied widely to the general population. Muscle Nerve 47: 884–889, 2013
Median nerve ultrasound in diabetic peripheral neuropathy with and without carpal tunnel syndrome
Hassan, Anhar , Watson, James C. , Boon, Andrea J. , Sorenson, Eric J. , Hunderfund, Andrea N. Leep

Mayo Clinic

Muscle & Nerve | September 15, 2012 | Volume: 47 | Issue: 3 | Pages: 437-439

10.1002/mus.23677 | PMID 23401087 Get It

Introduction: Median nerve ultrasound shows increased cross‐sectional area (CSA) in carpal tunnel syndrome (CTS) and diabetic peripheral neuropathy (PN). The role of ultrasound in diagnosing CTS superimposed on diabetic PN is unknown. The objective of this study is to evaluate ultrasound for diagnosis of CTS in diabetic PN. Methods: Prospective recruitment of diabetics with electrodiagnostically proven PN, subdivided into cases (with CTS) or controls (without CTS). The gold standard for CTS was clinical diagnosis. NCS were correlated with blinded median nerve CSA ultrasound measurements. Results: Eight cases (CTS) and eight controls (no CTS) were recruited. Nerve conduction studies (NCS): Median nerve distal latencies (antidromic sensory; palmar; lumbrical motor; and lumbrical motor to ulnar interosseous difference) were significantly prolonged in CTS cases. No ultrasound measurement (distal median CSA, wrist‐forearm ratio, wrist‐forearm difference) reached significance to detect CTS. Area under the curve was greatest for lumbrical distal latency by receiver operator characteristic analysis (0.85). Conclusions: In this pilot study, NCS may be superior to ultrasound for identification of superimposed CTS in diabetic PN patients, but larger numbers are needed for confirmation. Muscle Nerve 47: 437–439, 2013